Structural and functional principles of activation and regulation of the transient receptor potential channel TRPV3.
瞬时受体电位通道 TRPV3 激活和调节的结构和功能原理。
基本信息
- 批准号:10365295
- 负责人:
- 金额:$ 59.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2027-01-31
- 项目状态:未结题
- 来源:
- 关键词:Acne VulgarisAffinityAgonistAlkaloidsAnhydridesAtopic DermatitisBindingBinding SitesBiochemicalBiological AssayBiophysicsBoratesCalciumCalmodulinCamphorCellsChemicalsColorectalComplexCoumarinsCryoelectron MicroscopyCutaneousDNA Sequence AlterationDataDermatitisDetectionDevelopmentDiseaseDrug DesignElectrophysiology (science)Endogenous FactorsEsthesiaEugenolFluorescenceFluorescent DyesFunctional disorderFura-2GoalsGrowthGuanineHairHeatingHigh temperature of physical objectHumanIndividualIon ChannelIon Channel GatingKineticsKnowledgeLigandsLipid BilayersLipidsLungMaintenanceMalignant neoplasm of lungMeasurementMediatingMembrane LipidsMethodologyMethodsMolecularMolecular ConformationMolecular Sieve ChromatographyMutagenesisMutationNatural ProductsNociceptionOlmsted syndromePainPeriodicityPharmaceutical PreparationsPhase TransitionPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositolsPhysiologicalPhysiological ProcessesPlant ExtractsPlayPositioning AttributeProcessProteinsPruritusPsoriasisRegulationReportingResearchRoleRosaceaSignal TransductionSite-Directed MutagenesisSkinSkin NeoplasmsSkin PhysiologyStimulusStructural ModelsStructureTRP channelTechniquesTemperatureTestingThermodynamicsTransmembrane DomainVanilloidanalogantagonistbasecitralcolorectal cancer progressiondesigndisease-causing mutationfarnesyl pyrophosphategain of functioninhibitorisopentenyl pyrophosphatekeratinocytemutantnovel therapeutic interventionnovel therapeuticsoverexpressionpatch clampratiometricreceptorsensorskin barrierskin disordersmall moleculethermostabilitywound healing
项目摘要
PROJECT SUMMARY
Transient receptor potential (TRP) channels play important roles in numerous physiological processes and are
known as polymodal sensors that integrate a wide range of physical and chemical stimuli in cellular signaling.
TRPV3, a representative of the vanilloid subfamily of TRP channels, is predominantly expressed in skin
keratinocytes and implicated in cutaneous sensation, including thermo-sensation, nociception, and itch, in
addition to maintenance of the skin barrier, wound healing, and hair growth. The dysfunction of TRPV3 channels,
often a result of genetic mutations, is associated with numerous human skin diseases, including a
genodermatosis known as Olmsted syndrome, psoriasis, skin tumors, hair loss, cutaneous pain, itch, pruritic and
atopic dermatitis, rosacea, and acne vulgaris. Furthermore, overexpression of TRPV3 is implicated in the
development and progression of colorectal and lung cancer. Targeting TRPV3 for disease treatment requires
detailed information about the structure and function of this channel. We plan to study the TRPV3 channel
structure and function using a combination of different biophysical and biochemical methods. Our specific aims
are: (1) determine the molecular mechanisms of TRPV3 activation by small molecules and disease-causing
mutations, (2) establish structural bases of TRPV3 activation by heat, and (3) elucidate structural mechanisms
of TRPV3 inhibition. To achieve our goals, we will use the Fluorescence-detection Size Exclusion
Chromatography (FSEC) and thermostability assays to assess expression, assembly, homogeneity and stability
of the TRPV3 protein, cryo-electron microscopy (cryo-EM) to obtain structures of TRPV3 with or without disease-
associated mutations, at different temperatures and in complex with different activators, modulators and
inhibitors, as well as site-directed mutagenesis combined with electrophysiology, including single-channel
recordings from planar lipid bilayers and whole-cell patch-clamp recordings from HEK 293 cells, and ratiometric
measurements of intracellular Ca2+ concentration using calcium-sensitive fluorescent dye Fura-2 AM to assess
TRPV3 function and to critically test our structural models. Combining our structural and functional results, we
will decipher the mechanisms of TRPV3 regulation and gating. Achieving our aims will have a significant impact
on skin physiology and ion channel biophysics and will generate new knowledge that will assist in structure-
based drug design and help the development of new therapeutic strategies.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander Sobolevsky其他文献
Alexander Sobolevsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander Sobolevsky', 18)}}的其他基金
Structure and function of Transient Receptor Potential Channels
瞬时感受器电位通道的结构和功能
- 批准号:
10583880 - 财政年份:2023
- 资助金额:
$ 59.96万 - 项目类别:
Structural and functional principles of activation and regulation of the transient receptor potential channel TRPV3.
瞬时受体电位通道 TRPV3 激活和调节的结构和功能原理。
- 批准号:
10559520 - 财政年份:2022
- 资助金额:
$ 59.96万 - 项目类别:
Single-particle cryo-EM characterization of AMPA receptor functional states
AMPA 受体功能状态的单颗粒冷冻电镜表征
- 批准号:
9750158 - 财政年份:2018
- 资助金额:
$ 59.96万 - 项目类别:
Single-particle cryo-EM characterization of AMPA receptor functional states
AMPA 受体功能状态的单颗粒冷冻电镜表征
- 批准号:
10412995 - 财政年份:2018
- 资助金额:
$ 59.96万 - 项目类别:
Single-Particle Cryo-EM Characterization of AMPA Receptor Functional States
AMPA 受体功能状态的单粒子冷冻电镜表征
- 批准号:
10654933 - 财政年份:2018
- 资助金额:
$ 59.96万 - 项目类别:
Single-particle cryo-EM characterization of AMPA receptor functional states
AMPA 受体功能状态的单颗粒冷冻电镜表征
- 批准号:
9926319 - 财政年份:2018
- 资助金额:
$ 59.96万 - 项目类别:
Single-particle cryo-EM characterization of AMPA receptor functional states
AMPA 受体功能状态的单颗粒冷冻电镜表征
- 批准号:
9573053 - 财政年份:2018
- 资助金额:
$ 59.96万 - 项目类别:
Structure and function of Transient Receptor Potential channels
瞬时感受器电位通道的结构和功能
- 批准号:
9235633 - 财政年份:2017
- 资助金额:
$ 59.96万 - 项目类别:
Structure and Finction of AMPA subtype ionotropic glutamate receptors
AMPA 亚型离子型谷氨酸受体的结构和功能
- 批准号:
9091657 - 财政年份:2013
- 资助金额:
$ 59.96万 - 项目类别:
Structure and Finction of AMPA subtype ionotropic glutamate receptors
AMPA 亚型离子型谷氨酸受体的结构和功能
- 批准号:
8650439 - 财政年份:2013
- 资助金额:
$ 59.96万 - 项目类别:
相似海外基金
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10412227 - 财政年份:2022
- 资助金额:
$ 59.96万 - 项目类别:
Discovery of a High Affinity, Selective and β-arrestin Biased 5-HT7R Agonist
发现高亲和力、选择性和β-抑制蛋白偏向的 5-HT7R 激动剂
- 批准号:
10610473 - 财政年份:2022
- 资助金额:
$ 59.96万 - 项目类别:
Supplement to Discovery of a high affinity, selective and beta-arrestinbiased 5-HT7R Agonist Grant
对高亲和力、选择性和 β 抑制偏向 5-HT7R 激动剂发现的补充补助金
- 批准号:
10799162 - 财政年份:2022
- 资助金额:
$ 59.96万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6639179 - 财政年份:2001
- 资助金额:
$ 59.96万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6724797 - 财政年份:2001
- 资助金额:
$ 59.96万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6636512 - 财政年份:2001
- 资助金额:
$ 59.96万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6266928 - 财政年份:2001
- 资助金额:
$ 59.96万 - 项目类别:
NMDA RECEPTOR--AGONIST AFFINITY, EFFICACY/TRANSDUCTION
NMDA 受体——激动剂亲和力、功效/转导
- 批准号:
6539099 - 财政年份:2001
- 资助金额:
$ 59.96万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6326889 - 财政年份:2001
- 资助金额:
$ 59.96万 - 项目类别:
General Anesthetics and nAcCHOR Agonist Affinity
全身麻醉药和 nAcCHOR 激动剂亲和力
- 批准号:
6520329 - 财政年份:2001
- 资助金额:
$ 59.96万 - 项目类别: